JOSÉ LUIS
BALIBREA CANTERO
Forscher bis um 2009
EDUARDO
DÍAZ-RUBIO GARCÍA
Forscher bis um 2020
Publikationen, an denen er mitarbeitet EDUARDO DÍAZ-RUBIO GARCÍA (11)
2006
-
Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications
Cancer, Vol. 106, Núm. 3, pp. 541-551
2005
-
Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer
Oncology Reports, Vol. 13, Núm. 1, pp. 115-120
2004
-
Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
International journal of oncology, Vol. 24, Núm. 2, pp. 349-355
-
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications
British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988
2002
-
Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262
-
Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors
Oncogene, Vol. 21, Núm. 19, pp. 3089-3094
-
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors
Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860
1998
-
Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer
Oncology, Vol. 55, Núm. 3, pp. 249-257
1997
-
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
British Journal of Cancer, Vol. 76, Núm. 1, pp. 44-51
1996
-
Association of K-ras codon 12 transversions with short survival in non-small cell lung cancer
International Journal of Oncology, Vol. 9, Núm. 6, pp. 1307-1311
1995
-
Prevalence of p53 overexpression or mutations, but not K-ras mutations, in recurrent patients affected by colorectal carcinoma
International Journal of Oncology, Vol. 7, Núm. 6, pp. 1319-1325